Apotex Inc. v. AstraZeneca Canada Inc., [2016] N.R. Uned. 101 (FCA)
| Jurisdiction | Federal Jurisdiction (Canada) |
| Judge | Dawson, Stratas and Gleason, JJ.A. |
| Court | Court of Appeal (Canada) |
| Subject Matter | ESTOPPEL,COURTS,PATENTS OF INVENTION,PRACTICE |
| Citation | [2016] N.R. Uned. 101 (FCA),[2016] N.R. Uned. 101,2016 FCA 194 |
| Date | 05 July 2016 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
3 practice notes
-
Eli Lilly Canada Inc. v. Teva Canada Limited, 2018 FCA 53
...a judgment of the Federal Court that this Court has affirmed should be made to the Federal Court (AstraZeneca Canada Inc. v. Apotex Inc., 2016 FCA 194, [2016] F.C.J. No. 759 at paras. 15-20), under the Federal Courts Rules, SOR/98-106, the grounds on which a judgment may be set aside or v......
-
Pharma In Brief - FCA Considers Impact Of Successful Infringement Judgement On Prior Order For S. 8 Damages
...AstraZeneca Canada inc. v. Apotex Inc., 2016 FCA 194 (Court File No. A-311-15, A-187-12), aff'g 2015 FC 799 Drug: LOSEC® (omeprazole) Nature of case: Appeal from motion to vary decision under section 8 of the Patented Medicines (Notice of Compliance) Regulations (Regulations) Successful p......
-
Appeal of NOC Proceeding Dismissed as Moot, Despite Ongoing Section 8 Proceeding (Intellectual Property Weekly Abstracts - Week of July 25, 2016)
...of Motion to Vary Trial Decision in S. 8 case due to Later Infringement Finding Upheld on Appeal AstraZeneca Canada Inc. v. Apotex Inc., 2016 FCA 194 AstraZeneca has appealed a decision on its motion seeking to vary a judgment in a decision on the merits of a section 8 case. Damages were aw......
1 cases
-
Eli Lilly Canada Inc. v. Teva Canada Limited, 2018 FCA 53
...a judgment of the Federal Court that this Court has affirmed should be made to the Federal Court (AstraZeneca Canada Inc. v. Apotex Inc., 2016 FCA 194, [2016] F.C.J. No. 759 at paras. 15-20), under the Federal Courts Rules, SOR/98-106, the grounds on which a judgment may be set aside or v......
2 firm's commentaries
-
Pharma In Brief - FCA Considers Impact Of Successful Infringement Judgement On Prior Order For S. 8 Damages
...AstraZeneca Canada inc. v. Apotex Inc., 2016 FCA 194 (Court File No. A-311-15, A-187-12), aff'g 2015 FC 799 Drug: LOSEC® (omeprazole) Nature of case: Appeal from motion to vary decision under section 8 of the Patented Medicines (Notice of Compliance) Regulations (Regulations) Successful p......
-
Appeal of NOC Proceeding Dismissed as Moot, Despite Ongoing Section 8 Proceeding (Intellectual Property Weekly Abstracts - Week of July 25, 2016)
...of Motion to Vary Trial Decision in S. 8 case due to Later Infringement Finding Upheld on Appeal AstraZeneca Canada Inc. v. Apotex Inc., 2016 FCA 194 AstraZeneca has appealed a decision on its motion seeking to vary a judgment in a decision on the merits of a section 8 case. Damages were aw......